SEC Form 4 · accession 0001437749-18-010052
VIVEVE MEDICAL, INC. · VIVE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Debora Jorn
Director
Period of report
May 11, 2018
Accepted (ET)
May 15, 2018 · 7:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000879682
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Purchase)F1 | $1.97 | May 11, 2018 | A | 150,000 | A | — | May 10, 2028 | Common Stock | 150,000 | 150,000 | D |
Explanation of responses
- F1The Reporting Person is a participant in the Issuer's Amended and Restated 2013 Stock Option and Incentive Plan and received 150,000 stock options (the "Grant") on May 11, 2018 (the "Grant Date"). The Grant shall vest in equal monthly installments over a period of 24 months following the Grant Date subject to the Reporting Person's continued service to the Issuer through each vesting date.